Results 241 to 250 of about 13,254,189 (359)

References

, 1986
openaire   +2 more sources

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Harmonization of IGF1 immunoassays towards a higher-order LC-MS/MS reference anchor. [PDF]

Endocr Connect
Lentjes EGWM, Pratt MS, Kema IP, van Faassen M, Musson REA, Vos MJ.   +5 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Transcriptome assemblies for two drug-type cannabis chemotypes by long-read RNA sequencing. [PDF]

Plant Genome
Berkowitz O, Jost R, Ng S, Bacic A, Whelan J, Lewsey MG.   +5 more
europepmc   +1 more source

Peer Review #1 of "Identifying suitable reference genes for gene expression analysis in developing skeletal muscle in pigs (v0.1)"

, 2016
Guanglin Niu, Yalan Yang, Yuanyuan Zhang, Chaoju Hua, Zishuai Wang, Zhonglin Tang, Kui Li, C Andersen, J Jensen, T Orntoft, M Blaha, L Nemcova, K Kepkova, P Vodicka, R Prochazka, C Boosani, K Dhar, S Bustin, H Cho, J Chung, K Song, K Noh, B Kim, E Chung, K Ylaya, J Kim, T Kim, S Hewitt, J Kim, Costa Junior, D Peixoto-Souza, F Araujo, P Barbalho-Moulin, M Alves, V Gomes, E, Costa, X Feng, Y Xiong, H Qian, M Lei, D Xu, Ren Zq, C Fonvig, E Chabanova, J Ohrt, L Nielsen, O Pedersen, T Hansen, H Thomsen, J Holm, J Gabert, E Beillard, Vhj Van Der Velden, W Bi, D Grimwade, N Pallisgaard, G Barbany, G Cazzaniga, J Cayuela, H Cave, F Pane, Jle Aerts, De Micheli, D Thirion, X Pradel, V Gonzalez, M Viehmann, S Malec, M Saglio, G Van Dongen, Jjm, D Ginzinger, R Hu, C Fan, H Li, Q Zhang, Y Fu, J Huggett, K Dheda, S Bustin, Zumla, R Huis, S Hawkins, G Neutelings, M Jain, A Nijhawan, A Tyagi, J Khurana, B Jian, B Liu, Y Bi, W Hou, C Wu, Han Tf, J Kim, H Cho, J Kim, S Hur, T Kim   +99 more
openalex   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Respiratory Viral Co-Infections in SARS-CoV-2 Positive Patients in Burkina Faso: A Cross-Sectional Study. [PDF]

Health Sci Rep
Kaboré BWO, Gouba N, Ilboudo AK, Cissé A, Lingani M, Sawadogo C, Ouédraogo EW, Ouoba JB, Savadogo M, Tarnagda Z.   +9 more
europepmc   +1 more source

References of references in Robotics. References of references in mobile robotics.

Journal of the Robotics Society of Japan, 1998
openaire   +2 more sources